• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路移植术后再入院的发生率、成本和危险因素。

Incidence, Cost, and Risk Factors for Readmission After Coronary Artery Bypass Grafting.

机构信息

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

出版信息

Ann Thorac Surg. 2019 Jun;107(6):1782-1789. doi: 10.1016/j.athoracsur.2018.10.077. Epub 2018 Dec 14.

DOI:10.1016/j.athoracsur.2018.10.077
PMID:30553740
Abstract

BACKGROUND

Readmissions adversely affect hospital reimbursement and quality measures. We aimed to evaluate the incidence, cost, and risk factors for readmission following coronary artery bypass grafting (CABG).

METHODS

We queried the National Readmissions Database and isolated patients who underwent CABG from 2013 to 2014. We determined the top reasons for readmission and compared demographics, comorbidities, in-hospital outcomes, and costs between readmitted and nonreadmitted patients. Generalized linear regression was performed to identify independent predictors for readmission.

RESULTS

We identified 288,059 patients who underwent isolated CABG in the United States between 2013 and 2014. A total of 12.2% were readmitted within 30 days of discharge. Postoperative infection, heart failure, and arrhythmia were the most common reasons for readmission. The median time to readmit was 11 days, with a length of stay (LOS) of 6 days and a cost of $13,499 ± $201. Independent preoperative predictors for readmission were Medicaid status (odds ratio [OR], 1.33), female sex (OR, 1.32), chronic renal failure (OR, 1.26), greater than 4 Elixhauser comorbidities (OR, 1.20), chronic pulmonary disease (OR, 1.15), and nonelective operation (OR, 1.10) (all p < 0.05). In-hospital predictors included LOS greater than 10 days (OR, 1.52), acute kidney injury (OR, 1.30), atrial fibrillation (OR, 1.20), pneumonia (OR, 1.13), and discharge to skilled nursing facility (OR, 1.43) (all p < 0.05).

CONCLUSIONS

Thirty-day readmissions after CABG are frequent and related to preoperative comorbidities and complex postoperative course. Medicaid status, prolonged LOS, and disposition to a skilled nursing facility are strong predictors for 30-day readmission following CABG. Readmission reduction efforts should consider improvements for patients in these cohorts.

摘要

背景

再入院对医院的报销和质量措施有不利影响。我们旨在评估冠状动脉旁路移植术(CABG)后再入院的发生率、成本和危险因素。

方法

我们查询了国家再入院数据库,并从中筛选出 2013 年至 2014 年间接受 CABG 的患者。我们确定了再入院的主要原因,并比较了再入院和非再入院患者的人口统计学特征、合并症、住院结局和费用。使用广义线性回归确定再入院的独立预测因素。

结果

我们在美国确定了 2013 年至 2014 年间接受单独 CABG 的 288,059 名患者。出院后 30 天内再入院的比例为 12.2%。术后感染、心力衰竭和心律失常是再入院的最常见原因。再入院的中位时间为 11 天,住院时间(LOS)为 6 天,费用为 13,499±201 美元。再入院的独立术前预测因素包括医疗补助状态(比值比 [OR],1.33)、女性(OR,1.32)、慢性肾衰竭(OR,1.26)、大于 4 种 Elixhauser 合并症(OR,1.20)、慢性肺部疾病(OR,1.15)和非择期手术(OR,1.10)(均 p<0.05)。住院期间的预测因素包括 LOS 大于 10 天(OR,1.52)、急性肾损伤(OR,1.30)、心房颤动(OR,1.20)、肺炎(OR,1.13)和出院至熟练护理机构(OR,1.43)(均 p<0.05)。

结论

CABG 后 30 天内再入院较为常见,与术前合并症和复杂的术后病程有关。医疗补助状态、LOS 延长和向熟练护理机构的处置是 CABG 后 30 天内再入院的强有力预测因素。减少再入院的努力应考虑改善这些患者群体的状况。

相似文献

1
Incidence, Cost, and Risk Factors for Readmission After Coronary Artery Bypass Grafting.冠状动脉旁路移植术后再入院的发生率、成本和危险因素。
Ann Thorac Surg. 2019 Jun;107(6):1782-1789. doi: 10.1016/j.athoracsur.2018.10.077. Epub 2018 Dec 14.
2
Readmissions Following Isolated Coronary Artery Bypass Graft Surgery in the United States (from the Nationwide Readmissions Database 2010 to 2014).美国孤立性冠状动脉旁路移植术后再入院情况(2010 至 2014 年全国再入院数据库)。
Am J Cardiol. 2019 Jul 15;124(2):205-210. doi: 10.1016/j.amjcard.2019.04.018. Epub 2019 Apr 23.
3
Coronary artery bypass graft readmission rates and risk factors - A retrospective cohort study.冠状动脉旁路移植术再入院率及危险因素:一项回顾性队列研究。
Int J Surg. 2018 Jun;54(Pt A):7-17. doi: 10.1016/j.ijsu.2018.04.022. Epub 2018 Apr 17.
4
Predictors of readmission for complications of coronary artery bypass graft surgery.冠状动脉搭桥手术并发症再入院的预测因素。
JAMA. 2003 Aug 13;290(6):773-80. doi: 10.1001/jama.290.6.773.
5
Impact of New-Onset Postoperative Depression on Readmission Outcomes After Surgical Coronary Revascularization.术后新发抑郁症对冠状动脉旁路移植术后再入院结局的影响。
J Surg Res. 2019 Jan;233:50-56. doi: 10.1016/j.jss.2018.07.062. Epub 2018 Aug 17.
6
Safety of Early Discharge After Coronary Artery Bypass Grafting: A Nationwide Readmissions Analysis.冠状动脉旁路移植术后早期出院的安全性:全国再入院分析。
Ann Thorac Surg. 2024 Sep;118(3):701-710. doi: 10.1016/j.athoracsur.2024.05.045. Epub 2024 Jun 29.
7
Incidence, Predictors, and Outcomes of Early Acute Myocardial Infarction Following Coronary Artery Bypass Grafting.冠状动脉旁路移植术后早期急性心肌梗死的发生率、预测因素和结局。
Am J Cardiol. 2019 Oct 1;124(7):1027-1030. doi: 10.1016/j.amjcard.2019.06.023. Epub 2019 Jul 15.
8
Thirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysis.脊柱肿瘤手术后30天再入院及再次手术:一项国家外科质量改进计划分析。
Neurosurg Focus. 2016 Aug;41(2):E5. doi: 10.3171/2016.5.FOCUS16168.
9
Hospital variation in readmission after coronary artery bypass surgery in California.加利福尼亚州冠状动脉搭桥手术后再入院情况的医院差异。
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):729-37. doi: 10.1161/CIRCOUTCOMES.112.966945. Epub 2012 Sep 4.
10
Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?哪些临床和患者因素会影响全关节置换术后再入院的国家经济负担?
Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937. doi: 10.1007/s11999-017-5244-6.

引用本文的文献

1
Risk factor analysis and predictive model development for healthcare-associated infections post-coronary artery bypass grafting.冠状动脉旁路移植术后医疗相关感染的危险因素分析及预测模型构建
Front Public Health. 2025 Jul 3;13:1605272. doi: 10.3389/fpubh.2025.1605272. eCollection 2025.
2
No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.冠状动脉搭桥术中免接触式与传统静脉桥:多中心随机通畅性试验的三年随访
BMJ. 2025 Apr 30;389:e082883. doi: 10.1136/bmj-2024-082883.
3
Causes of and risk factors for unplanned readmission in a large cohort of patients undergoing major surgery: a retrospective cohort study.
大型队列中接受大手术患者计划外再入院的原因及危险因素:一项回顾性队列研究
Anaesthesia. 2025 Jun;80(6):652-661. doi: 10.1111/anae.16567. Epub 2025 Feb 16.
4
Incidence, timing and variation in unplanned readmissions within 30-days following isolated coronary artery bypass grafting.孤立性冠状动脉旁路移植术后30天内非计划再入院的发生率、时间及变化情况。
Int J Cardiol Heart Vasc. 2024 Nov 29;56:101552. doi: 10.1016/j.ijcha.2024.101552. eCollection 2025 Feb.
5
Impact of time from discharge to readmission on outcomes: an observational study from the US National Readmission Database.从出院到再入院的时间对结局的影响:来自美国国家再入院数据库的观察性研究。
BMJ Open. 2024 Aug 28;14(8):e085466. doi: 10.1136/bmjopen-2024-085466.
6
Risk Factors for Heart Failure Readmission After Cardiac Surgery.心脏手术后心力衰竭再入院的危险因素。
JACC Adv. 2023 Sep 6;2(8):100599. doi: 10.1016/j.jacadv.2023.100599. eCollection 2023 Oct.
7
Systematic Review and Meta-Analysis of the Financial Impact of 30-Day Readmissions for Selected Medical Conditions: A Focus on Hospital Quality Performance.特定医疗状况30天再入院财务影响的系统评价与Meta分析:聚焦医院质量绩效
Healthcare (Basel). 2024 Mar 29;12(7):750. doi: 10.3390/healthcare12070750.
8
Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)治疗左主干病变后的再住院情况:重新审视我们的视角。
J Am Coll Cardiol. 2024 Mar 19;83(11):1082-1084. doi: 10.1016/j.jacc.2024.01.028.
9
Increased Coronary Contraction to Thromboxane A2 in Cardiac Surgery Patients With Poorly Controlled Hypertension.心脏手术中高血压控制不佳患者的冠状动脉对血栓素 A2 的收缩反应增加。
J Surg Res. 2024 Feb;294:249-256. doi: 10.1016/j.jss.2023.10.004. Epub 2023 Nov 3.
10
A Retrospective Review of 30-Day Hospital Readmission Risk After Open Heart Surgery in Patients With Atrial Fibrillation.心房颤动患者心脏直视手术后30天再入院风险的回顾性研究
Cureus. 2023 Sep 22;15(9):e45755. doi: 10.7759/cureus.45755. eCollection 2023 Sep.